Spinal Nucleus Of Trigeminal Nerve is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Spinal Nucleus of the Trigeminal Nerve (SpV) is the principal sensory nucleus for facial sensation, receiving pain, temperature, and touch information from the face, mouth, and intracranial structures. It is one of the three main sensory nuclei of the trigeminal nerve system, alongside the principal (main sensory) nucleus and the mesencephalic nucleus.
| Property |
Value |
| Category |
Cell Type |
| Brain Region |
Brainstem (Medulla/Cervical Spinal Cord) |
| Cell Class |
Sensory Relay Neurons |
| Neurotransmitter |
Glutamate |
| Function |
Facial sensory processing, pain, temperature, touch |
¶ Morphology and Markers
The Spinal V nucleus has three anatomically and functionally distinct subnuclei:
- Subnucleus caudalis (SpVc): The most caudal portion, specialized for pain and temperature sensation. Often called the "pain center" of the trigeminal system.
- Subnucleus interpolaris (SpVi): Located between caudalis and oralis, processes mixed modalities.
- Subnucleus oralis (SpVo): Most rostral, handles tactile discrimination and proprioception.
- VGLUT2 (SLC17A6): Vesicular glutamate transporter - primary excitatory transmitter
- P2RX3: Purinergic receptor for ATP-mediated signaling
- CGRP: Calcitonin gene-related peptide - pain signaling
- IB4: Isolectin B4 binding - marks non-peptidergic nociceptors
- CALB1: Calbindin D-28k - calcium buffering protein
- NeuN (RBFOX3): Neuronal nuclear antigen - pan-neuronal marker
- Facial Pain Processing: Processes trigeminal pain including trigeminal neuralgia (tic douloureux)
- Temperature Sensation: Thermal information from face, mouth, and intracranial structures
- Touch and Pressure: Corneal reflex, facial tactile discrimination
- Oral Sensation: Tooth pain, mouth mucosa sensation, proprioception
- Reflex Integration: Jaw jerk reflex, corneal reflex pathways
- Receives primary afferents from trigeminal ganglion (CN V)
- Projects to thalamic ventroposteromedial nucleus (VPM)
- Connects to parabrachial nucleus for autonomic components
- Links to spinal cord dorsal horn for cervical integration
- May show alpha-synuclein pathology in late stages
- Contributes to orofacial pain and sensory disturbances
- Dysesthesia in PD patients may involve SpV dysfunction
- Primary disease of SpV afferents
- Typically involves demyelination of central processes
- May result from vascular compression of trigeminal root
- Bulbar-onset ALS shows early involvement
- Contributes to dysphagia and orofacial weakness
- Facial muscle spasticity may involve altered SpV input
- Multiple sclerosis: Demyelinating lesions
- Brainstem stroke: Lateral medullary syndrome (Wallenberg)
- Syringobulbia: Cavitary lesions affecting SpV
Key genes expressed in SpV neurons:
| Gene |
Function |
| VGLUT2/SLC17A6 |
Vesicular glutamate transporter |
| P2RX2/P2RX3 |
Purinergic receptors |
| TRPM8 |
Cold temperature receptor |
| TRPA1 |
Pain receptor (mustard oil) |
| CALB1 |
Calbindin D-28k |
| PDYN |
Prodynorphin (pain modulation) |
| TAC1 |
Tachykinin (substance P) |
- Carbamazepine: Sodium channel blocker - first-line for trigeminal neuralgia
- Oxcarbazepine: Similar mechanism, better tolerated
- Botulinum toxin: For refractory trigeminal neuralgia
- Gabapentin/Pregabalin: Calcium channel modulators
- Microvascular decompression (Jannetta procedure)
- Radiofrequency rhizotomy
- Glycerol rhizolysis
- Stereotactic radiosurgery (Gamma Knife)
- SpG (spinal ganglion) stimulation
- Peripheral nerve stimulation
- Novel sodium channel blockers (Nav1.7, Nav1.8)
- Rodent SpV: Well-characterized for orofacial pain studies
- Trigeminal nerve ligation models: Mimic neuropathic pain
- Transgenic mice: For studyingChannelopathies
- UnderstandingSpV sensitization in chronic pain
- Development of subtype-selective analgesics
- Optogenetic mapping of pain circuits
- Biomarker development for trigeminal neuropathic pain
- Rat SpV: Widely used for orofacial pain research
- Mouse models: Genetic studies of trigeminal pain pathways
- Transgenic mice: CGRP and P2RX3 reporter lines
- Glutamate excitotoxicity in SpV contributes to chronic pain
- Microglial activation in subnucleus caudalis mediates pain sensitization
- TRPM8/TRPA1 channel trafficking changes in inflammatory pain
- EAAT2 downregulation observed in chronic pain models
- Optogenetics: Mapping pain circuits in SpV
- Single-cell RNA-seq: Defining SpV neuronal subtypes
- Calcium imaging: In vivo monitoring of pain processing
- Brain-machine interfaces: Targeting SpV for chronic pain treatment
- P2RX3 expression: Potential biomarker for trigeminal pain
- CGRP levels: Correlate with migraine and facial pain
- VGLUT2 activity: Indicator of glutamatergic transmission
- fMRI: Functional imaging of SpV during pain tasks
- PET: TRPV1 receptor imaging in trigeminal pain
- DTI: White matter changes in trigeminal pathways
- Carbamazepine response predicts sodium channel involvement
- Botulinum toxin efficacy correlates with CGRP levels
The study of Spinal Nucleus Of Trigeminal Nerve has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Trigeminal brainstem sensory nuclei: organization and relationships. Neuroscience. 2018. PMID:29471174
- The spinal trigeminal nucleus: a gateway to pain. Brain Res Rev. 2009. PMID:18840425
- Trigeminovascular nociception: role of the spinal trigeminal nucleus. Cephalalgia. 2000. PMID:11061942
- Carbamazepine for trigeminal neuralgia. Cochrane Database Syst Rev. 2013. PMID:23440813
- Botulinum toxin for trigeminal neuralgia: systematic review. J Headache Pain. 2018. PMID:29619552